Error loading player: No playable sources found
4290
Therapies Targeting the Microbiome to Treat GI Disorders
Date
May 20, 2024
This product is not available for individual purchase, but it is available as part of the following products:
Full DDW 2024 On Demand Program available now!
SOCIETY: AGA This session will provide insight into the novel microbiome driven strategies to treat GI disorders. The talks in the session encompass the role of short-chain fatty acids and probiotics in disorders of GI motility and aging, the protective effects of Saccharomyces boulardii in colitis-associated colorectal cancer, and utility of fecal microbiota transplantation in inflammatory GI disorders.
Moderators
Mayo Clinic Minnesota
McMaster University
Related Products
Metabolism, Obesity, Microbiome, Diet, and Nutrition in GI Cancer
TUMOR PROMOTING ROLE OF EPIPLOIC ADIPOSE TISSUE IN COLON OF OBESE INDIVIDUALS IS MEDIATED VIA LIPID DROPLETS ASSOCIATED ADIPOSE TRIGLYCERIDE LIPASE (ATGL)
Gut Microbiota as the Orchestrator of Metabolic Disorders
SOCIETY: AGA The session will provide novel insights into the complex interactions between dietary choices, microbial dynamics, and metabolic health…
Shifting Paradigms: Are Microbes Steering Cancer Pathways?
SOCIETY: AGA This session will focus on novel findings linking specific microbial species and their metabolites with tumorigenesis specifically colon cancer, tumor microenvironment and immune responses…
Exploring the Dynamic Interactions Between Dietary Components, Microbiota, and Metabolic Health
SOCIETY: AGA The session will provide insights into the complex interplay between nutrition, microbial communities and metabolic health…
